PARIS, ONTARIO—(July 18, 2017) – Emblem Corp. (TSXV:EMC) (“Emblem” or the "Company") is pleased to announce that it will report its second quarter 2017 financial results for the period ended June 30, 2017, after market hours on August 28, 2017.
About Emblem Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) to cultivate and sell medical marihuana. Emblem carries out its principal activities producing marihuana from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations. For further information contact:
Ali Mahdavi Emblem Corp. (416) 962-3300 email@example.com
Submitted July 18, 2017 at 06:38AM by paisleyno2